Dr. Craig Eagle Joins OS Therapies as Strategic Advisor to Advance Oncology Therapeutic Programs

OS Therapies has announced the appointment of Dr. Craig Eagle as a strategic advisor to the company. The announcement, made on April 8, 2026, highlights Dr. Eagle’s extensive experience in oncology and pharmaceutical development as key assets that will contribute to the company’s ongoing efforts in advancing its therapeutic pipeline.

Dr. Eagle brings a wealth of expertise to OS Therapies, having held leadership roles in oncology-focused initiatives within the pharmaceutical industry. His background includes significant contributions to drug development strategies and clinical advancements aimed at addressing unmet medical needs in cancer treatment. The company stated that his advisory role will focus on guiding strategic decisions related to their therapeutic programs and expanding their impact within the healthcare sector.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI